Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination

TE Lew, JF Seymour - Journal of Hematology & Oncology, 2022 - Springer
BH3-mimetics are a novel drug class of small molecule inhibitors of BCL2 family proteins
which restore apoptosis in malignant cells. The only currently approved BH3-mimetic, the …

Biology and treatment of Richter transformation

A Condoluci, D Rossi - Frontiers in Oncology, 2022 - frontiersin.org
Richter transformation (RT), defined as the development of an aggressive lymphoma on a
background of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) …

A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL

N Jain, J Senapati, B Thakral, A Ferrajoli… - Blood …, 2023 - ashpublications.org
Richter transformation (RT) is a rare complication of chronic lymphocytic leukemia (CLL) that
has dismal outcomes. Upregulation of PD-1/PD-L1 drives immunological evasion in patients …

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial

O Al-Sawaf, R Ligtvoet, S Robrecht, J Stumpf… - Nature medicine, 2024 - nature.com
In patients with chronic lymphocytic leukemia, Richter transformation (RT) reflects the
development of an aggressive lymphoma that is associated with poor response to …

Richter syndrome: Novel insights into the biology of transformation

EM Parry, E Ten Hacken, CJ Wu - Blood, The Journal of the …, 2023 - ashpublications.org
Although the genetic landscape of chronic lymphocytic leukemia (CLL) has been broadly
profiled by large-scale sequencing studies performed over the past decade, the molecular …

Treatment of Richter's syndrome

PA Thompson, T Siddiqi - Hematology, 2022 - ashpublications.org
Richter's syndrome (RS) is an aggressive histologic transformation of chronic lymphocytic
leukemia (CLL), most commonly to diffuse large B-cell lymphoma (DLBCL). Outcomes are …

From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia

P Abrisqueta, F Nadeu, J Bosch-Schips… - Cancer Treatment …, 2023 - Elsevier
Richter transformation (RT) refers to the progression of chronic lymphocytic leukemia, the
most prevalent leukemia among adults, into a highly aggressive lymphoproliferative …

Richter syndrome: from molecular pathogenesis to druggable targets

S Mouhssine, G Gaidano - Cancers, 2022 - mdpi.com
Simple Summary Chronic lymphocytic leukemia represents the most frequent leukemia in
adults and evolves from an indolent phase to an aggressive lymphoma in 5–10% of the …

Treatment of richter transformation of chronic lymphocytic leukemia in the modern era

R Briski, J Taylor - Cancers, 2023 - mdpi.com
Simple Summary Though rare, Richter Transformation (RT) is a serious complication of
chronic lymphocytic leukemia. RT carries a high mortality rate and represents an unmet …

Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel

AJ Perissinotti, MR Bishop, J Bubalo, MB Geyer… - Cancer treatment …, 2023 - Elsevier
Introduction Tumor lysis syndrome (TLS), which occurs spontaneously or in response to
anticancer treatment, results in the release of intracellular potassium, phosphorus, and …